This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: metformin

Older antidiabetic drugs

March 2018 doi:10.5837/bjc.2018.007

Older antidiabetic drugs

Emma Johns, Gerry McKay, Miles Fisher

Abstract

(more…)

| Full text
In brief

September 2014 Br J Cardiol 2014;21:99

In brief

BJCardio Staff

Abstract

BSH Parliament day Professor Andrew Clark (President of the British Society for Heart Failure) is pictured here (centre) carrying out an echocardiogram in the House of Commons. He was at a BSH event to help raise awareness that a person diagnosed with heart failure is likely to have a worse prognosis than if they were diagnosed with most cancers. This is despite the availability of specialist heart failure services that can have a remarkable impact on a patient’s chance of survival, but for which there is inconsistent access over the UK leading to wide variations in care and outcomes. Over 60 MPs, Peers, and professional and patient groups

| Full text

November 2012 Br J Cardiol 2012;19:158–9

New diabetes guidelines stress individual patient needs

BJCardio Staff

Abstract

While general recommendations regarding the intensiveness of glycaemic therapy focused in the past on a HbA1c target below 7%, the new statement emphasises that goals must be individualised, with the precise target taking into account patient’s attitude and expected treatment efforts, the risk associated with glycaemia and other adverse effects, disease duration, life expectancy, other co-morbidities, established vascular complications, and the patient’s own resources and support system. It notes, for example, some patients may feel that the weight gain associated with a particular diabetes therapy is unacceptable, whereas others may cons

| Full text
Drugs for diabetes: part 1 metformin

September 2010 Br J Cardiol 2010;17:231–4

Drugs for diabetes: part 1 metformin

James G Boyle, Gerard A McKay, Miles Fisher

Abstract

(more…)

| Full text

March 2004 Br J Cardiol 2004;11:138-43

Will prevention of type 2 diabetes reduce the future burden of cardiovascular disease? The evidence base today

ohn HB Scarpello

Abstract

No content available

| Full text

March 2003 Br J Cardiol 2003;10:128-36

Antidiabetic drugs

Clifford J Bailey, Caroline Day

Abstract

No content available

| Full text

February 2002 Br J Cardiol 2002;9:115-19

United Kingdom Prospective Diabetes Study: implications for metformin

Clifford J Bailey, Ian W Campbell

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now